Infective endocarditis. Considerations for the timing of surgical intervention and type of infecting microorganism. 1997

S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
Second Department of Surgery, Nippon Medical School, Tokyo, Japan.

To determine the appropriate timing for surgical intervention in infective endocarditis (IE), we evaluated 24 patients (17 males, 6 females, with one included twice) who underwent surgical intervention for IE of native valves (NVE, n = 21) and prosthetic valves (PVE, n = 3) between January 1989 and September 1994. The mean age was 41 +/- 13 years (range 6 to 64 years). The most common infective organisms were Staphylococcus (33% of NVE) and Streptococcus (19% of NVE), with five NVE patients (24%) negative for blood culture. The PVE patients showed a different pattern of infecting organisms, with Enterococcus in one and Pseudomonas in another. From the resected valve culture and pathological findings, 12 patients were in the active stage at operation. Two in-hospital deaths occurred for a mortality rate of 8.7% (2/23). Further, surgical interventions were performed earlier with Staphylococcal infections than with Streptococcal infections, because hemodynamic compromise presented more progressively in the former. Also resected valve cultures and the pathological findings showed that a persistent infectious process existed in many cases of Staphylococcal infection in spite of intensive antibiotic therapy. In conclusion, we suggest that internists make referrals for surgical intervention for patients with NVE or PVE as early as possible in the active stage of infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D012017 Referral and Consultation The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. Consultation,Gatekeepers, Health Service,Hospital Referral,Second Opinion,Consultation and Referral,Health Service Gatekeepers,Hospital Referrals,Referral,Referral, Hospital,Referrals, Hospital,Consultations,Gatekeeper, Health Service,Health Service Gatekeeper,Opinion, Second,Opinions, Second,Referrals,Second Opinions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260 Female Females
D006349 Heart Valve Diseases Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). Heart Valvular Disease,Valvular Heart Diseases,Disease, Heart Valvular,Heart Disease, Valvular,Heart Valve Disease,Heart Valvular Diseases,Valve Disease, Heart,Valvular Disease, Heart,Valvular Heart Disease
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006351 Heart Valves Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles. Cardiac Valves,Cardiac Valve,Heart Valve,Valve, Cardiac,Valve, Heart,Valves, Cardiac,Valves, Heart

Related Publications

S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
May 2010, The Journal of heart valve disease,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
January 2018, Hemodialysis international. International Symposium on Home Hemodialysis,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
April 2008, Annales de cardiologie et d'angeiologie,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
May 2009, Herz,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
June 2005, Harefuah,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
August 1996, Cardiology clinics,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
January 2012, Interactive cardiovascular and thoracic surgery,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
December 2002, Asian cardiovascular & thoracic annals,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
January 1989, Texas Heart Institute journal,
S Yamauchi, and M Ochi, and T Nitta, and T Yajima, and R Bessho, and H Imura, and K Yamada, and J Ninomiya, and M Ikeshita, and S Tanaka
July 1991, Zhonghua wai ke za zhi [Chinese journal of surgery],
Copied contents to your clipboard!